Patents by Inventor Chris Stannard

Chris Stannard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized Angiopoietin-2 Antibodies And Uses Thereof
    Publication number: 20130280251
    Abstract: Stabilized antibodies directed to Angiopoeitin-2 and uses of such antibodies are described. Nucleic acid and amino acid sequences, hybridomas or other cell lines for expressing such antibodies are also provided.
    Type: Application
    Filed: July 1, 2013
    Publication date: October 24, 2013
    Applicant: MedImmune Limited
    Inventors: Vahe Bedian, William Dall'Acqua, Herren Wu, Michael Bowen, Jeffrey Brown, Chris Stannard, Ralph Minter, Andrew Buchanan
  • Stabilized angiopoietin-2 antibodies and uses thereof
    Patent number: 8507656
    Abstract: Stabilized antibodies directed to Angiopoeitin-2 and uses of such antibodies are described. Nucleic acid and amino acid sequences, hybridomas or other cell lines for expressing such antibodies are also provided.
    Type: Grant
    Filed: January 28, 2009
    Date of Patent: August 13, 2013
    Assignee: MedImmune Limited
    Inventors: Vahe Bedian, William Dall'Acqua, Herren Wu, Michael Bowen, Jeffrey Brown, Chris Stannard, Ralph Minter, Andrew Buchanan
  • Stabilized Angiopoietin-2 Antibodies And Uses Thereof
    Publication number: 20110044998
    Abstract: Stabilized antibodies directed to Angiopoeitin-2 and uses of such antibodies are described. Nucleic acid and amino acid sequences, hybridomas or other cell lines for expressing such antibodies are also provided.
    Type: Application
    Filed: January 28, 2009
    Publication date: February 24, 2011
    Inventors: Vahe Bedian, William Dall'Acqua, Herren Wu, Michael Bowden, Jeffrey Brown, Chris Stannard